Hrt Financial LP Processa Pharmaceuticals, Inc. Transaction History

Hrt Financial LP

  • $17 Billion
  • Q2 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 09, 2024
SELL
$0.18 - $0.84 $1,373 - $6,408
-7,629 Reduced 39.43%
11,717 $3,000
Q3 2023

Nov 13, 2023
BUY
$0.24 - $0.53 $4,643 - $10,253
19,346 New
19,346 $4,000

About Processa Pharmaceuticals, Inc.

PCSA Quotes by TradingView
  • Ticker PCSA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 15,856,200
  • Market Cap $18.4M
  • Description
  • Processa Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, focuses on the development of drug products for the treatment of patients with unmet medical needs in the United States. Its lead product candidate is PCS499, an oral tablet that is in Phase 2B clinical trials for the treatment of ulcerative and non-ulcerative necrobiosi...
More about PCSA
Track This Portfolio

Track Hrt Financial LP Portfolio

Follow Hrt Financial LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

News

Stay updated on Hrt Financial LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email